Inactive Instrument

Analyst Reco. 4D pharma plc

Equities

Chardan Capital Downgrades 4D pharma to Neutral from Buy on Likelihood of Share Dilution	27/22/27	MT
Chardan Capital Downgrades 4D pharma to Neutral from Buy	27/22/27	MT
Ladenburg Thalmann Downgrades 4D Pharma to Neutral From Buy	27/22/27	MT
Ladenburg Thalmann Adjusts Price Target on 4D Pharma to $37 From $35, Reiterates Buy Rating	24/22/24	MT
4D PHARMA : Ladenburg Thalmann Starts 4D Pharma at Buy With $35 Price Target	13/21/13	MT

No results for this search